A Pair of Identical Twins Discordant for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Differ in Physiological Parameters and Gut Microbiome Composition. — CFSMEATLAS
A Pair of Identical Twins Discordant for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Differ in Physiological Parameters and Gut Microbiome Composition.
Giloteaux, Ludovic, Hanson, Maureen R, Keller, Betsy A · The American journal of case reports · 2016 · DOI
Quick Summary
This study compared two identical twins—one with ME/CFS and one without—to understand what causes the illness. The affected twin showed reduced exercise capacity, abnormal responses to physical exertion, and differences in immune markers and gut bacteria compared to the healthy twin. These findings suggest that ME/CFS involves problems with how the body responds to exercise and changes in the gut bacteria that may trigger inflammation.
Why It Matters
By studying genetically identical twins with different ME/CFS status, researchers can isolate disease-specific factors from genetic background. This approach identified concrete physiological abnormalities—abnormal post-exercise immune activation and altered gut microbial composition—that may explain ME/CFS symptoms and could guide future biomarker development and therapeutic targets for the larger patient population.
Observed Findings
Affected twin showed lower peak VO2 and peak workload during exercise compared to unaffected twin.
Abnormal 13% reduction in ventilatory anaerobic threshold during second CPET in affected twin, whereas unaffected twin showed normal reproducibility.
Exaggerated post-exercise increases in resistin, sCD40L, and sFasL in affected twin compared to unaffected twin.
Lower gut bacterial diversity in affected twin with reduced Faecalibacterium and Bifidobacterium populations.
Expanded bacteriophages (Caudovirales order) in affected twin's microbiome.
Inferred Conclusions
ME/CFS involves dysfunctional immune activation following exercise, distinct from normal physiological stress response.
Gut dysbiosis with reduced beneficial bacteria and elevated bacteriophages may contribute to mucosal inflammation in ME/CFS.
Two-day CPET combined with blood and microbiome analysis may provide diagnostic biomarkers for ME/CFS when applied to larger cohorts.
Genetic factors alone do not determine ME/CFS susceptibility; environmental or acquired factors appear necessary for disease development.
Remaining Questions
What environmental, viral, or other acquired factors trigger ME/CFS development in genetically predisposed individuals?
What This Study Does Not Prove
This study does not prove that dysbiosis or altered immune activation *causes* ME/CFS, as this is a case report of two individuals rather than a causal study. The findings cannot be generalized to all ME/CFS patients without validation in larger cohorts. Additionally, it remains unclear whether the microbiome changes are a cause or consequence of ME/CFS.